These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 22586796)
1. Advances in the treatment of melanoma. Lacy KE; Karagiannis SN; Nestle FO Clin Med (Lond); 2012 Apr; 12(2):168-71. PubMed ID: 22586796 [No Abstract] [Full Text] [Related]
2. What new immunotherapeutic techniques are currently being investigated for the treatment of melanoma? Donnelly OG; Melcher AA; Vile RG; Pulido J Immunotherapy; 2012 Aug; 4(8):749-51. PubMed ID: 22947000 [No Abstract] [Full Text] [Related]
3. [New paradigms and metaphors in cutaneous melanoma treatment]. Piérard GE; Nizet JL; Humbert P Rev Med Liege; 2016 Dec; 71(12):562-566. PubMed ID: 28387097 [TBL] [Abstract][Full Text] [Related]
4. Narrowing the knowledge gaps for melanoma. Slipicevic A; Herlyn M Ups J Med Sci; 2012 May; 117(2):237-43. PubMed ID: 22339359 [TBL] [Abstract][Full Text] [Related]
5. Current advances and perspectives in the treatment of advanced melanoma. Livingstone E; Zimmer L; Vaubel J; Schadendorf D J Dtsch Dermatol Ges; 2012 May; 10(5):319-25. PubMed ID: 22432863 [TBL] [Abstract][Full Text] [Related]
6. Advances in the systemic treatment of metastatic melanoma. Yushak M; Kluger HM; Sznol M Oncology (Williston Park); 2013 May; 27(5):374-81. PubMed ID: 25184258 [TBL] [Abstract][Full Text] [Related]
7. Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part II: Management of stage IV disease. Fox MC; Lao CD; Schwartz JL; Frohm ML; Bichakjian CK; Johnson TM J Am Acad Dermatol; 2013 Jan; 68(1):13.e1-13; quiz 26-8. PubMed ID: 23244384 [TBL] [Abstract][Full Text] [Related]
8. [Metastatic melanoma: some hope from ipilimumab and vemurafenib]. Piérard-Franchimont C; Piérard GE Rev Med Liege; 2012 Feb; 67(2):64-8. PubMed ID: 22482234 [TBL] [Abstract][Full Text] [Related]
9. Latest developments in the treatment of melanoma: 'a penicillin moment for cancer'? Retsas S J R Soc Med; 2011 Jun; 104(6):269-72. PubMed ID: 21659402 [No Abstract] [Full Text] [Related]
10. The new paradigm of systemic therapies for metastatic melanoma. Volpe VO; Klufas DM; Hegde U; Grant-Kels JM J Am Acad Dermatol; 2017 Aug; 77(2):356-368. PubMed ID: 28711086 [TBL] [Abstract][Full Text] [Related]
11. Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo. Fukumoto T; Fujiwara S; Sakaguchi M; Oka M; Kiyota N; Ejima Y; Nakajima K; Nishigori C Eur J Dermatol; 2017 Apr; 27(2):177-178. PubMed ID: 27873735 [No Abstract] [Full Text] [Related]
12. How recent advances in immunotherapy are changing the standard of care for patients with metastatic melanoma. Wolchok J Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii15-21. PubMed ID: 22918923 [TBL] [Abstract][Full Text] [Related]
13. [New hope in metastatic melanoma treatment?]. Guillot B Ann Dermatol Venereol; 2012 Oct; 139(10):693-4. PubMed ID: 23122388 [No Abstract] [Full Text] [Related]
14. Controversies in the management of advanced melanoma: "gray" areas amid the "black and blue". Jarkowski A; Norris L; Trinh VA Ann Pharmacother; 2014 Nov; 48(11):1456-68. PubMed ID: 25056920 [TBL] [Abstract][Full Text] [Related]
15. New targeted therapies in melanoma. Kudchadkar RR; Gonzalez R; Lewis K Cancer Control; 2013 Oct; 20(4):282-8. PubMed ID: 24077404 [TBL] [Abstract][Full Text] [Related]
16. Drug treatment for melanoma: progress, but who pays? Kefford RF Med J Aust; 2012 Aug; 197(4):198-9. PubMed ID: 22900855 [No Abstract] [Full Text] [Related]
17. Industry makes strides in melanoma. Garber K Nat Biotechnol; 2010 Aug; 28(8):763-4. PubMed ID: 20697383 [No Abstract] [Full Text] [Related]
18. Are we entering a new era in melanoma treatment? Lesson from ASCO 2011. Mouawad R; Spano JP; Khayat D Melanoma Res; 2011 Oct; 21(5):377-9. PubMed ID: 21900791 [No Abstract] [Full Text] [Related]
19. [Melanoma- finally good news]. Wicki A; Arnold AW; Itin PH; Zippelius A Praxis (Bern 1994); 2013 May; 102(11):667-70. PubMed ID: 23692905 [TBL] [Abstract][Full Text] [Related]
20. Vemurafenib and ipilimumab: new agents for metastatic melanoma. Banaszynski M; Kolesar JM Am J Health Syst Pharm; 2013 Jul; 70(14):1205-10. PubMed ID: 23820456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]